Obsessive-Compulsive Disorder Market Report 2026

Obsessive-Compulsive Disorder Market Overview

• Obsessive-Compulsive Disorder market size has reached to $0.67 billion in 2025 • Expected to grow to $1 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Impact Of Increasing Mental Illness Prevalence In The Market Growth • Market Trend: Advancements In Obsessive-Compulsive Disorder Treatment By Newport Healthcare • North America was the largest region in 2025.

What Is Covered Under Obsessive-Compulsive Disorder Market?

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurring, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to reduce anxiety. These actions often interfere with daily life and cause significant distress. Common themes include cleanliness, orderliness, and fear of harm. Treatment typically involves therapy and medication. The main drug class of obsessive-compulsive disorder includes selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), serotonin antagonist and reuptake inhibitors (SARIs), and tricyclic antidepressants (TCAs). Selective serotonin reuptake inhibitors (SSRIs) are medications that work by increasing serotonin levels in the brain, preventing its reabsorption into nerve cells. These drugs are commonly indicated for conditions such as major depressive disorder, anxiety disorders, and attention deficit hyperactivity disorder (ADHD). The distribution channels for these medications include hospital pharmacies, retail pharmacies, and other distribution channels and are used by various end users such as hospitals, specialty clinics, and other healthcare facilities.

What Is The Obsessive-Compulsive Disorder Market Growth Forecast?

The obsessive-compulsive disorder market size is expected to see strong growth in the next few years. It will grow to $1 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to advancements in ai-driven mental health tools, increasing demand for telepsychiatry services, rising adoption of personalized treatment approaches, growing r&d in novel ocd drugs, expanding mental health awareness and government support programs. Major trends in the forecast period include rising adoption of digital therapeutics for ocd management, increasing integration of ai-based symptom tracking tools, growing focus on personalized medicine and targeted therapies, rising use of telepsychiatry and remote patient monitoring, increasing research on genomic and neurobiological drivers of ocd.

Global Obsessive-Compulsive Disorder Market Segmentation

1) By Treatment Type: Pharmacological, Non-Pharmacological 2) By Patient Population: Children, Adolescents, Adults, Elderly 3) By End User: Hospitals, Specialty Clinics Or Psychiatry Centers, Home Healthcare Or Teletherapy 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Or E-Commerce Subsegments: 1) By Pharmacological: Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Antipsychotics, Anxiolytics 2) By Non-Pharmacological: Cognitive Behavioral Therapy (CBT), Exposure And Response Prevention (ERP), Psychotherapy, Digital Therapy

What Is The Driver Of The Obsessive-Compulsive Disorder Market?

The increase in prevalence of mental illness is expected to propel the growth of the obsessive-compulsive disorder market going forward. Mental illness refers to a wide range of mental health conditions that affect mood, thinking, behavior, and overall functioning. Mental illness is increasing due to a combination of heightened awareness and diagnosis, lifestyle changes, chronic stress, global crises, and growing social, economic, and environmental pressures. Obsessive-compulsive disorder sheds light on the intricate mechanisms of mental illness, helping to advance understanding, diagnosis, and treatment approaches for broader mental health conditions. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization of psychiatrists and trainee psychiatrists, 43% of adults reported experiencing higher levels of anxiety compared to the previous year, increasing from 37% in 2023 and 32% in 2022. Therefore, the increase in the prevalence of mental illness is driving the growth of the obsessive-compulsive disorder industry.

Key Players In The Global Obsessive-Compulsive Disorder Market

Major companies operating in the obsessive-compulsive disorder market are Pfizer Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Zydus Cadila, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Par Pharmaceutical, GlaxoSmithKline plc, H Lundbeck A/S, Johnson & Johnson Services Inc, Takeda Pharmaceutical Company Limited, Viatris Inc, Apotex Inc, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Roche Holding AG, Alvogen Inc, Wockhardt Ltd, Sebela Pharmaceuticals Inc, Otsuka Pharmaceutical Co Ltd.

Global Obsessive-Compulsive Disorder Market Trends and Insights

Major companies operating in the obsessive-compulsive disorder market are focusing on mental health treatment to develop more effective therapeutic solutions. Mental health treatment refers to various therapies and interventions designed to manage and alleviate mental health conditions, including medications, counseling, and lifestyle changes. For instance, in October 2023, Newport Healthcare, a US-based healthcare company, introduced Newport Healthcare's Obsessive-Compulsive Disorder Treatment Program, now open to teens and young adults. This initiative is uniquely tailored to address the specific developmental and psychological needs of young individuals grappling with OCD and related disorders. Leveraging a nationwide network, the program ensures accessibility to evidence-based therapies, including Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP), and family-focused interventions. With a holistic care model, it integrates mental health treatment with mindfulness, physical wellness, and life skills development to foster comprehensive recovery.

What Are Latest Mergers And Acquisitions In The Obsessive-Compulsive Disorder Market?

In August 2023, Talkiatry, a US-based healthcare company, partnered with NOCD to enhance OCD care by seamlessly integrating their services. With this partnership, they aim to streamline OCD treatment by combining specialized ERP therapy and psychiatric care for improved patient outcomes. NOCD is a US-based mental health technology company specializing in providing online therapy for obsessive-compulsive disorder (OCD).

Regional Outlook

North America was the largest region in the obsessive-compulsive disorder market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Obsessive-Compulsive Disorder Market?

The obsessive-compulsive disorder market includes revenues earned by entities by providing services such as diagnosing, treating, and managing mental health conditions and related products including benzodiazepines, neurostimulation devices, and ERP therapy tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Obsessive-Compulsive Disorder Market Report 2026?

The obsessive-compulsive disorder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the obsessive-compulsive disorder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.